Benign insulinomas usually express glucagon-like peptide-1 receptors (GLP-1R), and imaging with different radiolabelled-exendin-4 compounds (i.e., 68Ga-NOTA-exendin-4) is recommended, with a sensitivity up to 90%. Here, GLP1R is linked to pancreatic insulinoma.